Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | GIII | PVH |
|---|---|---|
| Price | $26.95 | $78.33 |
| Change today | ▲ 0.63% | ▲ 0.15% |
| Market cap | $1.16B | $3.61B |
| Return, 3 months | -20.8% | +1.4% |
| Return, year to date | -6.0% | +17.0% |
| Return, 1 year | +0.9% | -6.9% |
| P/E (TTM) | 8.9 | -23.1 |
| P/B | 0.6 | 0.8 |
| P/E percentile vs own 5y | 81st | 0th |
| Dividend yield | 1.11% | 0.19% |
| Revenue growth (YoY, latest qtr) | -9.6% | -3.2% |
| Net profit growth (YoY) | +84.8% | -145.9% |
| Gross margin | 44.4% | 58.8% |
| Operating margin | 8.0% | 8.0% |
| Net margin | 4.8% | -1.9% |
| Return on equity | 7.7% | -3.5% |
| Analyst target vs. price | +33.6% | +12.5% |
| Analyst buy share | 67% | 44% |
| RSI (14) | 34 | 59 |
| 30-day volatility | 42.4% | 36.4% |
| Max drawdown, 1 year | -27.0% | -30.6% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
